CN · Field Sheet
FIELD SHEET — ECHINACEA MFI-ECHINA-20261019-FS
Survey index / ECHINACEA

Echinacea.

Echinacea purpurea / Echinacea angustifolia / Echinacea pallida
Coneflower; upper-respiratory and immune claims.
SEALED MFI-ECHINA-20261019-FS · RELEASED 2026-10-19
SHEET FINGERPRINTMFI-ECHINA-20261019-FS
473INCLUDED
1,603EXCLUDED
71DUPLICATE
95NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,242records surveyed
473studies
27claims graded
113observations
7,938graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-72a8545c161d6201GRADE VERY_LOW
echinacea constituents — immune
direction BENEFIT · dose 30 mg/kg; 70 mg/kg · duration 4 month; 7 days; 8 week
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
12bound studies
Bound studies (4 shown of 12)
STU-01553d985137a631
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-076d43293cd9c0d2
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-2b77b5b3466a8326
IN_VITRO · IN_VITRO · 2019 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-30ba441d56de4eee
ANIMAL · ANIMAL · 2023 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 64 · validated
observation p < 0.05 · validated
observation p < 0.0001 | p < 0.001 · failed extraction
Opposition screen
SCREEN · 31 candidates considered · 3 bound as opposing
SYNTHESIS SYN-344d8357cc98b6 — outcome QUALITATIVE_ONLY · BENEFIT ×12 · not_assessed_quantitatively · 12 members
PROVENANCE → epmc:33416087, epmc:41599708, epmc:30644442 · PKG dd845a8c8f9b77f5…
CLAIM · CLM-107f788b3fd79ce2GRADE VERY_LOW
echinacea constituents — inflammation
direction BENEFIT · dose 30 mg/kg; 70 mg/kg · duration 8 week
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
8bound studies
Bound studies (4 shown of 8)
STU-01553d985137a631
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
5 endpoints
STU-076d43293cd9c0d2
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-1169f377532cc673
RCT · HUMAN · 2022 · 8 week · RoB SOME_CONCERNS
2 endpoints
STU-30ba441d56de4eee
ANIMAL · ANIMAL · 2023 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 8 week · failed extraction
observation p < 0.05 · validated
observation 114 · validated
Opposition screen
SCREEN · 21 candidates considered · 3 bound as opposing
SYNTHESIS SYN-85fb71fe458f10 — outcome QUALITATIVE_ONLY · BENEFIT ×8 · not_assessed_quantitatively · 8 members
PROVENANCE → epmc:33416087, epmc:41599708, epmc:35061237 · PKG dd845a8c8f9b77f5…
Bounded preview — representative records only. The full release ships 27 claims and 113 observations.